Pentixapharm Holding AG (ETR:PTP) | Finanzwire

Basculer en Français

9774	Companies
195575	Keywords
126557	Articles
103967	Press releases

Headlines Articles Press releases Pentixapharm Holding AG

Home
Companies
Pentixapharm Holding AG

BRIEF

published on 04/25/2025 at 15:44, 9 months 4 days ago

Pentixapharm to Showcase Innovative Antibody GT-008 at AACR 2025

Cancer Therapy Pentixapharm GT-008 Antibody Glycan-Dependent CD24 Targeting
PRESS RELEASE

published on 04/25/2025 at 15:39, 9 months 4 days ago

Pentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025
Pentixapharm to present novel CD24 antibody GT-008 for solid tumors at AACR 2025, showcasing glycan-dependent mechanism for targeted therapy

Solid Tumors Pentixapharm AACR 2025 GT-008 CD24 Antibody
BRIEF

published on 04/24/2025 at 14:05, 9 months 5 days ago

Pentixapharm Signs Manufacturing Deal for Yttrium-90 Therapy

Clinical Trials Eckert & Ziegler Radiopharmaceuticals Pentixapharm Yttrium-90
PRESS RELEASE

published on 04/24/2025 at 14:00, 9 months 5 days ago

Pentixapharm Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Eckert & Ziegler SE
Pentixapharm signs manufacturing agreement for Yttrium-90-based PentixaTher with Eckert & Ziegler SE to produce CXCR4-targeting radiotherapeutic doses for clinical trials

Clinical Trials Eckert & Ziegler SE Pentixapharm Y90-PentixaTher Radiotherapeutic
BRIEF

published on 04/15/2025 at 08:22, 9 months 14 days ago

Pentixapharm Holding AG Reports 2024 Financial Results and 2025 Outlook

Research And Development Financial Results 2024 2025 Financial Forecast Radiopharmaceutical Innovation Pentixapharm Strategy
PRESS RELEASE

published on 04/15/2025 at 08:17, 9 months 14 days ago

Pentixapharm Holding AG Releases Financial Results for 2024 and Announces Guidance for the 2025 Financial Year
Pentixapharm Holding AG releases 2024 financial results with EUR 12.8 million net loss and guides for EUR 23.5 million loss in 2025, focusing on R&D and operating expenses

Financial Results 2024 Net Loss 2025 Pentixapharm
BRIEF

published on 03/03/2025 at 14:43, 10 months 26 days ago

Pentixapharm Holding AG Announces Board Changes

Supervisory Board Board Changes Leadership Transition Pentixapharm Governance Dr. Andreas Eckert
PRESS RELEASE

published on 03/03/2025 at 14:38, 10 months 26 days ago

Changes in the Supervisory Board and Management Board of Pentixapharm Holding AG
Personnel changes in both the Supervisory Board and Management Board of Pentixapharm Holding AG have been implemented as of March 1, 2025, aligning the boards of the parent and subsidiary companies

Supervisory Board Management Board Berlin Personnel Changes Pentixapharm Holding AG
BRIEF

published on 02/13/2025 at 14:15, 11 months 16 days ago

Pentixapharm to Present Pioneering Bladder Cancer Treatment at ASCO-GU 2025

Bladder Cancer Lu177-PentixaTher CXCR4 Target ASCO-GU 2025 Radioligand Therapy
PRESS RELEASE

published on 02/13/2025 at 14:10, 11 months 16 days ago

First-In-Human Data about the Treatment of Muscle-Invasive Bladder Cancer with Pentixapharm’s Lu177-PentixaTher to be Presented at ASCO-GU 2025
Pentixapharm presents first-in-human data on Lu177-PentixaTher for Muscle-Invasive Bladder Cancer at ASCO-GU 2025, showing potential for bladder preservation and targeted treatment

Pentixapharm Lu177-PentixaTher ASCO-GU 2025 Muscle-Invasive Bladder Cancer Radioligand-Therapy

Accesswire

Published on 01/30/2026 at 02:15, 4 hours 25 minutes ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 6 hours 40 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 7 hours 40 minutes ago

PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/29/2026 at 18:45, 11 hours 55 minutes ago

Silver Spruce Appoints Vice-President of Exploration
Published on 01/29/2026 at 18:00, 12 hours 40 minutes ago

PPX Mining Announces Grant of Restricted Share Units and Deferred Share Units

View all ACCESSWIRE

EQS Group

Published on 01/30/2026 at 04:30, 2 hours 9 minutes ago

A First Look at AI in the Real World: AWE 2026 Opens This March in Shanghai
Published on 01/30/2026 at 03:35, 3 hours 4 minutes ago

Bybit Unveils 2026 Vision as "The New Financial Platform," Expanding Beyond Exchange Into Global Financial Infrastructure
Published on 01/30/2026 at 00:07, 6 hours 32 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Appointment of independent non-executive director
Published on 01/29/2026 at 21:02, 9 hours 37 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 21:01, 9 hours 39 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc

Les Echos

Published on 01/29/2026 at 18:00, 12 hours 40 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 12 hours 55 minutes ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 12 hours 55 minutes ago

Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 17:40, 13 hours ago

ALTEN: Annual revenue 2025
Published on 01/29/2026 at 10:07, 20 hours 32 minutes ago

Deezer confirms demonetization of up to 85% of AI-music streams due to fraud and moves to sell AI-detection tech

View all LES ECHOS COMFI WIRE